Bio-Techne Corp
TECH
Nasdaq
Health Technology
Biotechnology
72.12
USD
+0.35
+0.49%
Ditutup: 07-17 20:00 (UTC+0)
72.17
USD
+0.05
+0.07%
Setelah jam pasar: 07-18 00:00 (UTC+0)

TECH Statistik Utama

Tinggi
72.12
Buka
71.60
Volume
3.07M
Rendah
71.50
Cierre anterior
71.77
Nilai Perdagangan
221.03M
Tertinggi 52M
72.16
Volume relatif
0.367
Amplitudo (%)
0.86%
Terendah 52M
43.20
Tingkat Perputaran
1.96%
Kap Pasar
11.18B
P/E (TTM)
103.59
P/E (Tahunan)
153.447
P/B
5.39
P/S
9.28
Laba per Saham (EPS)
0.696
Dividen (TTM)
0.317
Imbal Hasil Dividen
0.45%
Saham beredar
156.56M
Mata uang
USD

TECH Kinerja Harga

7 hari
30 hari
90 hari
180 hari
Sejak awal tahun
1 Tahun
TECH Distribusi Arus Dana
TECH Volume Short Sale Harian
TECH Riwayat Short Interest
As of 2026-07-18, the Bio-Techne Corp (TECH) stock price today is 72.12. Based on this price, the company has a market capitalization of $11.18B, with a P/E ratio of 103.59. On 2026-07-18, TECH traded between 71.50 and 72.12. Today’s stock price is 0.87% above the daily low and 0.00% below the daily high, placing TECH mendekati batas atas its most recent trading range. Trading volume currently stands at 3.07M, compared with an average daily volume of 8.38M. This suggests that trading activity is jauh di bawah level biasanya than usual. Over the past year, Bio-Techne Corp shares have traded between 43.20 and 72.16. At today’s price, TECH is 66.94% above its 52-week low and 0.06% below its 52-week high.
Nama Perusahaan
Bio-Techne Corp
Sektor
Health Technology
Industri
Biotechnology
Bursa
Nasdaq
Jumlah Karyawan
3,100
Ukuran Lot
100
Mata uang
USD
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
Cari
Lebih